ctrl K

Watchlist Price Alert

NewAmsterdam Pharma N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

19.13

-0.62 (-3.14%)

At close: Jun 17, 2025, 10:52 AM

NewAmsterdam Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	771.74M	340.45M	438.52M	53.09M	7.86M
Short-Term Investments	62.45M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	718.35K	112.79M
Other Long-Term Assets	n/a	35K	146K	-353	-112.79M
Receivables	21.3M	1.88M	2.07M	4.86M	n/a
Inventory	n/a	n/a	21.5K	-735	n/a
Other Current Assets	n/a	n/a	n/a	5.78M	n/a
Total Current Assets	863.41M	346.79M	448.13M	58.87M	9.22M
Property-Plant & Equipment	673K	101K	144K	190K	12K
Goodwill & Intangibles	534K	170K	83.16M	n/a	n/a
Total Long-Term Assets	1.21M	306K	83.45M	908K	12K
Total Assets	864.62M	347.1M	531.58M	59.78M	9.23M
Account Payables	4.74M	16.92M	11.85M	7.04M	487.06K
Deferred Revenue	6.01M	8.94M	13.01M	3.61M	n/a
Short-Term Debt	246K	n/a	n/a	n/a	11.65M
Other Current Liabilities	91.03M	15.96M	5.55M	519.69K	-266.28K
Total Current Liabilities	106.92M	49.9M	35.46M	9.88M	12.81M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	7.79M	6.75M	-14.68K	n/a
Total Long-Term Liabilities	202K	8.81M	11.6M	111K	9.95M
Total Liabilities	107.12M	58.7M	47.06M	9.99M	12.81M
Total Debt	448K	60K	118K	164K	11.65M
Common Stock	13.44M	10.17M	599.19M	83.88M	2.5M
Retained Earnings	n/a	-316.97M	-119.36M	-34.68M	-6.08M
Comprehensive Income	4.47M	4.42M	4.69M	591K	n/a
Shareholders Equity	757.5M	288.39M	484.52M	49.79M	-3.58M
Total Investments	62.45M	-31.08M	n/a	718.35K	112.79M